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Original Article
Geriatric rehabilitation for patients
with advanced chronic obstructive
pulmonary disease: A naturalistic
prospective cohort study on feasibility
and course of health status
Eléonore F van Dam van Isselt1,2, Monica Spruit1,
Karin H Groenewegen-Sipkema3,
Niels H Chavannes1 and Wilco P Achterberg1
Abstract
In view of the worldwide aging population, disease-specific geriatric rehabilitation (GR) programs are
needed. Therefore, we developed and implemented a postacute GR program for patients with advanced
chronic obstructive pulmonary disease (COPD) (the GR-COPD program). The aim of this study is to inves-
tigate the feasibility of the GR-COPD program and to present clinical data on patient characteristics and
course of functional capacity and health status. This is a naturalistic prospective cohort study of patients with
advanced COPD. A total of 61 patients entered the GR-COPD program and were eligible to participate in
this study. All patients suffered from advanced COPD, and comorbidities were frequent. On admission, func-
tional capacity and health status were severely limited but showed significant and clinically relevant improve-
ment during the GR-COPD program. Patients with advanced COPD admitted to hospital for an acute
exacerbation suffer from severely impaired functional capacity and poor health status. Development and
implementation of a postacute GR program for these patients are feasible and likely to offer substantial
improvements. Further research is essential and should focus on designing a controlled intervention trial
to investigate the efficacy of the program.
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Introduction
Geriatric rehabilitation (GR) has emerged as a pro-
mising field of interest, showing that it has the poten-
tial to improve outcome measurements related to
morbidity and mortality in elderly people.1 GR is usu-
ally organized as a form of integrated care and does
not differ from rehabilitation medicine in its multidis-
ciplinary, patient-centred approach. However, geria-
tric patients differ in many ways from younger
patients who need rehabilitation. Besides having mul-
timorbidity, their disabilities are usually multicausal.
Pre-existent functional limitations are caused not only
by comorbidity conditions but also by physiological
conditions, such as sarcopenia.2 Furthermore, patients
admitted for GR often suffer from concurrent diseases
and complications interfering with the rehabilitation
treatment. In this sense, GR operates at the crossroads
of geriatric medicine and rehabilitation medicine.2
Considering the worldwide aging population, there
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is a growing need for programs designed for geriatric
patients. However, the development, implementation
and evaluation of disease-specific GR programs
(other than orthopaedic and general) are lacking.1
One field in which development of disease-specific
GR programs can be meaningful is progressive organ
failure, such as chronic obstructive pulmonary disease
(COPD). Prevalence of COPD is rising worldwide
and disease severity is strongly related to age.3
Patients with advanced COPD suffer from a high
symptom burden, deteriorating functional capacity
and declining quality of life; moreover, their prog-
nosis is poor, especially after hospital admission for
an acute exacerbation.4–6
Pulmonary rehabilitation (PR) emerged as a rec-
ommended standard of care for patients with sympto-
matic COPD7 and is effective in advanced and both
stable and postacute COPD in reducing the risk of
readmission and mortality and improving health-
related quality of life (HRQoL) and exercise capac-
ity.7,8 Poor health status and prognosis in patients with
advanced COPD also call for implementation of pal-
liative care methods. Palliative care should start early
in the disease trajectory (when patients become symp-
tomatic) and should be combined with active treat-
ment and life-prolonging care.9
In clinical practice, however, availability of PR
programs is limited and patients with advanced
COPD are often excluded from these programs
because of their limited training capacity and frequent
concurrent diseases and complications due to comor-
bidity, all interfering with the rehabilitation program.
Furthermore, although the palliative care needs of
patients advanced COPD are increasingly being
recognized, palliative care is still scarcely received
by patients with advanced COPD.10 A disease-
specific GR program that is more adjusted to the
needs and possibilities of this group of patients could
be an interesting option. Besides offering an adjusted,
low-intensity program, GR in the Netherlands is coor-
dinated by an elderly care physician who is specia-
lized in rehabilitation of frail, often elderly, patients
with complex disabilities and multimorbidity.11 The
importance of medical practitioners as an essential
part of GR and their findings about causes, comorbid-
ity and prognosis being incorporated into the rehabili-
tation plan, was recently stated.12 Furthermore,
integration of rehabilitation medicine and palliative
care is common practice in GR, and patients with
advanced COPD might benefit from this integrated
approach.13
Considering these facts, our group developed and
implemented a postacute GR program for patients
with advanced COPD (the GR-COPD program).14
Aim of the present study is to investigate feasibility
of the program and to present clinical data on patient




This is a naturalistic prospective cohort study
of patients with advanced COPD admitted to a
postacute GR program in a skilled nursing facility
(SNF). Baseline data (T0) were collected within
3 days after admission to the SNF. Patient and dis-
ease characteristics, functional capacity, nutritional
status, psychosocial functioning and health status
were registered. At discharge from the SNF (T1),
functional capacity, nutritional status and health
status were measured again. Data were collected
from May 2009 until January 2011.
Setting and study population
Patients with severe (Global Initiative for Chronic
Obstructive Lung Disease (GOLD)15 stage 3) to very
severe (GOLD stage 4) COPD admitted to the hospi-
tal for an acute exacerbation were selected for the GR-
COPD program by a pulmonologist. Indication for the
GR-COPD program was considered appropriate when
patients suffered from high symptom burden and/or a
substantial decline in functional capacity without suf-
ficient recovery during hospital stay. Furthermore, a
multidisciplinary approach was required to achieve
improvement in functional capacity and health status
instead of physical therapy alone and patients had
to be motivated. Patients who lacked motivation,
or patients with prominent psychiatric or cognitive
dysfunction interfering with rehabilitation, were
excluded from the program. All patients admitted
to the GR-COPD program were eligible to partici-
pate in this study. Data were collected from the
patient’s file by the patient’s physician and trans-
ferred to an anonymous data file using Statistical
Package for the Social Sciences (SPSS) software
(SPSS 20; SPSS, Chicago, Illinois, USA).
The GR-COPD program
In the Netherlands, GR is organized as a form of inte-
grated and transmural care and is provided at SNFs,
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usually situated in nursing homes.16 SNFs offer post-
acute restorative treatment with a multidisciplinary
patient-centred approach in a therapeutic living envi-
ronment.16 During the study period, GR was funded
by the government’s Exceptional Medical Expenses
Act (AWBZ), which offers a weekly average of
18–22 h of nursing care and 4 h of individual therapy.
The SNF at which the current study was conducted
has a multidisciplinary team that offers pulmonary,
orthopaedic, neurological and general GR. This SNF
is situated at a separate ward of the nursing home and
has a capacity of 60 beds with a mean length of admis-
sion (LOA) of 39 days. On average, 350 patients are
admitted for GR each year. The GR-COPD program
was developed in 2009 by the multidisciplinary team
of the SNF in close collaboration with the pulmonol-
ogist and physiotherapist from the pulmonary depart-
ment of the local hospital. Development of the
program was based on national and international
guidelines on PR and palliative care.9,17 The multidis-
ciplinary team of the SNF consists of an elderly care
physician,11 a skilled nurse, a physiotherapist, a psy-
chologist, an occupational therapist, a speech and lan-
guage pathologist, a dietician and a social worker.
During development and implementation, each mem-
ber of the team received specific training on PR tech-
niques within their own field of interest. A detailed
description of the program has recently been pub-
lished.14 The GR-COPD program contains several
modules concerning different aspects of rehabilitation
and palliative care: optimizing pulmonary medication
use and inhalation techniques, support smoking cessa-
tion, adequate symptom control, physiotherapy
(endurance and strength training, inspiratory muscle
training, relaxation techniques, breathing regulation
skills and mucus evacuation techniques), occupa-
tional therapy, analysis of nutritional status and
dietary supplementation, analysis of speech, breath-
ing and swallowing techniques, psychosocial inter-
vention (mostly aimed at depression, anxiety or
adverse coping strategies), education focusing on
self-management strategies, peer support contact
and advance care planning. Goal setting is tailored
to the individual patient and the program is weekly
evaluated and adjusted (as needed) by the multidis-
ciplinary team and the pulmonologist who makes
monthly visits to all patients. All patients follow
a standardized 6-week program and assignment to
therapies is stringent. The program contains a min-
imum of six 40-min physiotherapy sessions per
week, usually three endurance and three strength
training sessions. Group sessions are combined
with individual training. Furthermore, training of
breathing, huffing and relaxation techniques are
offered once a week. Occupational therapy is given
once or twice a week in 30- to 45-min sessions and
analysis and evaluation of nutritional status is done
by the dietician every week. Patients participate
in weekly group sessions, which are supervised
by the psychologist, and are aimed at education
of patients and relatives on self-management strate-
gies and peer support contact.
Measurements and instruments
The following patient and disease characteristics
were registered: age, sex, marital status, disease
severity (GOLD stage, forced expiratory volume in
1 s as percentage of predicted (FEV1%pred)), long-
term oxygen therapy (LTOT) (yes/no), smoking sta-
tus (smoker/nonsmoker), LOA during hospital stay
and LOA during rehabilitation. Comorbidity was
assessed using the modified Cumulative Illness
Rating Scale (CIRS)18. The CIRS consists of 13
items (organ or disease systems) with a severity
scale ranging from 0 to 4 for each item. Total score
is the sum of all items (range 0–56), with scores
>10 indicating severe impairment.
Nutritional status was measured by the body mass
index (BMI) and the fat-free mass index (FFMI). The
BMI was calculated as weight/height2 (in kilogram
per square metre) and was categorized in two groups:
underweight (<21 kg/m2) and not underweight
(21 kg/m2).19 The FFMI was measured during hos-
pital stay using bioelectrical impedance analysis.
Depletion was considered when the FFMI was
16 kg/m2 in men and 15 kg/m2 in women.19
Functional capacity
The modified 20-point Barthel index (BI) measures
activities of daily living and is a valid, reliable and
widely used instrument to assess improvement during
rehabilitation programs.20 The total score ranges from
0 to 20, with 20 representing complete functional
independence. The minimal clinically important dif-
ference (MCID) for the BI is not well established
for COPD patients. In stroke patients, the MCID of
the BI is þ1.85.21
The 6-min walk test (6MWT) is a practical, easy to
perform and widely used instrument to measure exer-
cise capacity in COPD patients. The MCID for the
6MWT in patients with severe COPD isþ26 (+2) m.22
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Peripheral muscle strength was measured as hand-
grip force (HF) using a hand dynamometer. Total
scores (right hand þ left hand) are given in kilogram
force, and normative data are age and sex dependent.23
Psychosocial functioning
The Hospital Anxiety and Depression Scale (HADS)
is a valid and reliable screening instrument for symp-
toms of anxiety and depression. It has two 7-item sub-
scales, one for anxiety and the other for depression.
A score of 8 points or higher on either subscale
indicates a higher risk for the presence of a clinically
relevant anxiety disorder or depression.24
Health status
Health status was measured using the Clinical COPD
Questionnaire (CCQ).25 The CCQ is a validated and
reliable 10-item, self-administered questionnaire.
Items are scored on a Likert scale ranging from 0 to
6. The final score is the sum of all items divided by
10; higher scores indicate a worse health status. The
CCQ consists of the subdomain symptom, functional
state and mental state, and scores for these three
domains can be calculated separately. The MCID of
the CCQ total score is 0.4.26
Statistical analysis
All data were processed using the SPSS (SPSS 20.0;
SPSS). Descriptive analyses were used for general
baseline patient characteristics, disease characteristics
and data from measurements on admission. Categori-
cal variables are described as frequencies, while con-
tinuous variables are tested for normality and are
presented as mean and SD or median and interquartile
range (IQR) in case of skewed data. Continuous vari-
ables were compared between T0 and T1 using a
paired samples t-test or Mann–Whitney test, as appro-
priate. We defined statistical significance at p  0.05
(two-sided level of significance).
Results
General patient characteristics
Of the 63 consecutive patients who entered the pro-
gram during the period from May 2009 until January
2011, 2 were excluded from this study because of a
different diagnosis (1 due to asthma and 1 due to small
airway disease). One patient dropped out due to lack
of motivation and was discharged back home. Two
patients died during the program; in both patients it
was concluded that rehabilitation was no longer feasi-
ble. For these patients, end-of-life care communica-
tion and advance care planning (e.g. do not attempt
cardiopulmonary resuscitation, no more admissions
to the hospital) had been performed and death was
expected. Overall, 91% (n ¼ 53) of the patients were
discharged back home after a median LOA of 35 days
(IQR 21–61). Four patients were discharged to a resi-
dential care facility and one patient was discharged to
a nursing home (Figure 1).
Table 1 presents the patient and disease character-
istics on admission to the GR-COPD program (T0).
All patients had advanced COPD (GOLD stage 3
(n ¼ 29) or GOLD stage 4 (n ¼ 32)), with a mean
FEV1%pred of 32.9 (10.8). Of these, 17 (28%)
patients were on LTOT. Comorbidity was prevalent,
as 41% of the patients had a CIRS score 10, indicat-
ing severe impairment due to comorbidity. Organ and
disease systems (except respiratory) showing the
highest mean scores were cardiac (0.97, 35% 2),
musculoskeletal and integumentary (0.85, 33% 2)
and endocrine–metabolic (0.75, 31% 2).
Patients entering the GR-COPD program
between May 2009 and Jan 2011
n = 63




Lost to follow-up 
-lack of motivation; n = 1
-death; n = 2 
Discharge to 
-residential care facility; n = 4






Figure 1. Flow chart of patients.
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Measurements on admission
Table 2 presents the outcomes of all measurements on
admission (T0) to and discharge from the GR-COPD
program. Functional capacity was impaired, as on
admission both the BI and the 6MWT showed care
dependency and limited exercise capacity. Peripheral
muscle strength showed that 25 patients (41%) had an
HF below the normative value. Although the mean
BMI was within normal range, 20 patients (33%) had
a BMI < 21 kg/m2, indicating underweight. Depletion
of the FFMI was present in 44% (n ¼ 27) of all
patients. HADS scores showed that 47% of the
patients had a higher risk (score of 8) for anxiety
and 43% for depression. The mean CCQ score was
3.5 (+0.9), indicating severely limited health status.
Course of functional capacity during the GR-
COPD program
There was a significant and clinically relevant
improvement of functional capacity during the GR-
COPD program (Table 2, Figure 2). The median BI
improved from 17 (IQR 15–18) to 20 (IQR 17–20),
and the mean 6MWT from 208 m (+119) to 274 m
(+122) at discharge. In 41 patients, the BI improved
2 or more points (>MCID); in 2 patients, the BI on
discharge was lower than on admission; and in 9
patients, the BI did not change during the program.
In 71.7% of the patients, the 6MWT improved 26
m (>MCID). In two patients, the 6MWT did not
change; and in six patients, the 6MWT decreased. The
nutritional status measured by the mean BMI showed
no significant improvement. However, the number
of patients with underweight (BMI < 21 kg/m2)
decreased from 20 to 12 (p ¼ 0.007). Improvement
in health status was also significant and clinically rel-
evant: the mean score of the CCQ improved from 3.5
(+0.9) on admission to 2.2 (+1.0) at discharge.
Discussion
Main findings
The main finding of this study is that, in patients
with advanced COPD, who suffered a recent exacer-
bation, comorbidity is frequent, functional capacity
is impaired and health status is severely limited.
Furthermore, nutritional status is often impaired and
many patients are at risk for an anxiety or depressive
disorder. Nevertheless, during the GR-COPD pro-
gram, functional capacity and health status showed
substantial and clinically relevant improvement. This
implies that, although these patients are severely lim-
ited in training capacity, a postacute GR program is
feasible and is likely to offer substantial benefits.
Strength and limitations
To the best of our knowledge, this is the first study
focusing on feasibility, patient characteristics and
course of functional capacity in patients with
advanced COPD admitted to a postacute GR program.
The current study was not designed as an intervention
trial but as a naturalistic prospective cohort study.
Therefore, a control group was not part of this study
and the current study can also be seen as a pilot study.
Further research is essential and should focus on
designing a controlled intervention trial to investigate
the efficacy of the program. Other limitations are pos-
sible population bias due to criteria used to select
patients for the program and the fact that we were
unable to collect information on patients who were
selected for the program but refused to participate.
Since these latter patients were discharged back home
from the hospital, health status and functional capac-
ity of our population are probably worse than that of
the initial population who was indicated for the pro-
gram in the hospital. This could bias the generalizabil-
ity of our results. We used the BI to measure
Table 1. Patient and disease characteristics on admission
(baseline/T0) to the GR-COPD program.a
Number of patients 61
Age in years (SD) 68.9 (9.9)
Sex: woman, n (%) 30 (49)
Living alone, n (%) 28 (46)
LOA-H in days (IQR) 8 (7–11)
LOA-SNF in days (IQR) 35 (21–61)
GOLD 3, n (%) 29 (48)
GOLD 4, n (%) 32 (52)
FEV1%pred (SD) 32.9 (10.8)
LTOT, n (%) 17 (28)
Comorbidity, CIRS (total score) (SD) 9.6 (4.3)
Smoker, n (%) 10 (16.5)
aCategorical variables are described as frequencies, while contin-
uous variables are tested for normality and are presented as mean
and SD or median and IQR in case of skewed data. GR-COPD:
geriatric rehabilitation program for patients with advanced
chronic obstructive pulmonary disease; LOA-H: length of admis-
sion during hospital stay; LOA-SNF: length of admission during
rehabilitation; IQR: interquartile range; GOLD: Global Initiative
for Chronic Obstructive Lung Disease; FEV1%pred: forced expira-
tory volume in 1 s as percentage of predicted; LTOT: long-term
oxygen therapy; CIRS: Cumulative Illness Rating Scale.
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functional capacity. However, the BI might not be the
most suitable instrument to measure functional capac-
ity and impairment in patients with COPD due to the
ceiling effect and insensitivity to change at the upper
level of the scale.27 Nevertheless, the BI is a widely
used instrument and recent literature shows that it can
be used in patients with COPD.28 Our results also
show the ceiling effect of the BI, but improvement
was still clinically relevant.
Few data are available on GR programs specifi-
cally designed for patients with advanced COPD.
A recent systematic review on the efficacy of GR
failed to identify one disease-specific program for
geriatric patients who has been well evaluated, other
than orthopaedic and general GR.1 Studies on the
effect of PR in elderly patients with COPD are scarce
but show positive outcomes of PR programs for rela-
tively older COPD patients.29,30 However, compared
with our population, these studies included only stable
COPD patients with less severe airflow obstruction
and functional impairment. Furthermore, excluded
from these latter studies were patients with comorbid
diseases that are likely to limit exercise capacity.
Studies on the effect of postacute PR programs in
elderly COPD patients are also scarce. Puhan et al.8
performed a systematic review to assess the effect
of PR on future hospital admissions, mortality,
HRQoL and exercise capacity, in patients with COPD
after a recent exacerbation. The authors concluded
that postacute PR is a highly effective and safe inter-
vention to reduce hospital admissions and mortality
and to improve HRQoL. Of the nine studies that met
Figure 2. Course of functional capacity and health status from admission (T0) to discharge (T1).
Table 2. Outcomes of measurements on admission (T0) to and discharge from (T1) the GR-COPD program.
Measurement T0 T1 p
Functional capacity
BI (IQR) 17 (15–18) 20 (17–20) <0.001b
6MWT (m) (SD) 208 (119) 274 (122) <0.001a
HF (kgf) (SD) 52.0 (17.0) 55.6 (17.5) <0.001a
HF < norm value, n (%) 25 (41) 18 (30) 0.024c
Nutritional status
BMI (kg/m2) (SD) 23.3 (4.7) 23.8 (4.0) 0.051a
BMI < 21 kg/m2, n (%) 20 (33) 12 (20) 0.007c
FFMI (kg/m2) (SD) 15.8 (2.3) – –
Psychosocial functioning
HADS_Anxiety 7.5 (4.2) – –
HADS_Depression 7.4 (4.6) – –
Health status
CCQ (SD) 3.5 (0.9) 2.2 (1.0) <0.001a
Categorical variables are described as frequencies, while continuous variables are tested for normality and are presented as mean and
SD or median and IQR. Continuous variables were compared between T0 and T1 using a paired samples t-testa or Mann–Whitney testb,
as appropriate. Categorical variables were compared between T0 and T1 using w2 testsc. GR-COPD: geriatric rehabilitation program
for patients with advanced chronic obstructive pulmonary disease; BI: Barthel index; 6MWT: 6-min walk test; HF: handgrip force; BMI:
body mass index; FFMI: fat-free mass index; HADS: Hospital Anxiety and Depression Scale; CCQ: Clinical COPD Questionnaire.
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their eligibility criteria, five investigated the effect of
an inpatient PR program that followed immediately
after hospital admission.31–35 Of these studies, one was
conducted at an intensive care unit31 and one study
included patients with less severe airflow limitation
compared with our population.32 Three small studies
reported positive effects on exercise capacity,33
health-care utilization34 and HRQoL,35 of a postacute
PR program in populations who were more similar to
ours with regard to age, lung function and exercise
capacity. However, in those studies comorbidity was
not always measured,35 or patients with significant
comorbidities were excluded from the PR program.33
Although there are differences between our population
and the populations described in studies on the effect of
(postacute) PR program, these data are in line with our
results, indicating that postacute rehabilitation in
patients with advanced COPD is feasible, safe and can
probably offer substantial benefits.
A notable finding of the present study is that the
mean age of the patients who entered the GR-COPD
program was 68.9 years, which is relatively young
considering that this is a GR program. However, indi-
cation for the GR-COPD program was based on dis-
ease severity and the presence of impaired
functional capacity and health status with insufficient
recovery during hospital stay. Age was not an inclu-
sion or exclusion criterion. This suggests that, in
patients with COPD, advanced disease with limited
functional capacity and health status can be present
at a relatively young age. Nevertheless, 54% of the
patients were aged 70 years and almost 20% of our
population were aged 80 years.
Implications for future research
Although our results suggest that the GR-COPD pro-
gram is effective in this specific group of patients, our
study design did not include a control group and a ran-
domized controlled trial is compulsory to confirm
these findings. As literature on this topic is scarce,
further research is essential. Studies should focus on
defining appropriate outcome measurements to iden-
tity which patient outcomes can be achieved and sus-
tained and identify patient characteristics that can
predict which patients with advanced COPD are most
likely to benefit from an postacute GR program.
Conclusions
Patients with advanced COPD admitted to hospital
for an acute exacerbation suffer from frequent
comorbidities, severely impaired functional capacity
and poor health status. Development and implementa-
tion of a postacute GR program for this group of
patients are feasible and can probably offer substan-
tial improvements.
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